Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Alpelisib × Clear all

Phase

Phase 1 20 Phase 2 6 Phase 3 2 Phase 1/2 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Saline Solution 24 Metformin 23 Zoledronic Acid 22 Dexamethasone 21 Cytarabine 19 Cyclophosphamide 19 Bupivacaine 17 Sodium Chloride 16 Propofol 15 Vincristine 14 Morphine 14 Methotrexate 14 Letrozole 14 Dexmedetomidine 14 Fentanyl 13 Imiquimod 12 Doxorubicin 12 Docetaxel 12 Prednisolone 11 Oxycodone 11 Mercaptopurine 11 Bevacizumab 11 Rituximab 10 Everolimus 10 Cisplatin 10 Capecitabine 10 Acetaminophen 10 nilotinib 9 enzalutamide 9 Ropivacaine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05631795 2025-12-03

ALPINIST

Novartis

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡